Annual EBIT
-$22.92 M
+$8.03 M+25.94%
December 31, 2023
Summary
- As of March 10, 2025, INKT annual earnings before interest & taxes is -$22.92 million, with the most recent change of +$8.03 million (+25.94%) on December 31, 2023.
- During the last 3 years, INKT annual EBIT has fallen by -$9.12 million (-66.12%).
- INKT annual EBIT is now -66.12% below its all-time high of -$13.80 million, reached on December 31, 2020.
Performance
INKT EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$1.88 M
+$1.19 M+38.63%
September 30, 2024
Summary
- As of March 10, 2025, INKT quarterly earnings before interest & taxes is -$1.88 million, with the most recent change of +$1.19 million (+38.63%) on September 30, 2024.
- Over the past year, INKT quarterly EBIT has stayed the same.
- INKT quarterly EBIT is now -122.19% below its all-time high of -$848.20 thousand, reached on December 31, 2020.
Performance
INKT Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$14.29 M
+$3.34 M+18.95%
September 30, 2024
Summary
- As of March 10, 2025, INKT TTM earnings before interest & taxes is -$14.29 million, with the most recent change of +$3.34 million (+18.95%) on September 30, 2024.
- Over the past year, INKT TTM EBIT has stayed the same.
- INKT TTM EBIT is now -164.34% below its all-time high of -$5.40 million, reached on September 30, 2020.
Performance
INKT TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
INKT EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +25.9% | 0.0% | 0.0% |
| 3 y3 years | -66.1% | 0.0% | 0.0% |
| 5 y5 years | -3.1% | 0.0% | 0.0% |
INKT EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +25.9% | at high | +76.4% | at high | +59.0% |
| 5 y | 5-year | -66.1% | +25.9% | -122.2% | +85.9% | -164.3% | +59.0% |
| alltime | all time | -66.1% | +25.9% | -122.2% | +85.9% | -164.3% | +59.0% |
MiNK Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.88 M(-38.6%) | -$14.29 M(-18.9%) |
| Jun 2024 | - | -$3.07 M(-19.8%) | -$17.62 M(-15.7%) |
| Mar 2024 | - | -$3.83 M(-30.4%) | -$20.90 M(-8.8%) |
| Dec 2023 | -$22.92 M(-25.9%) | -$5.50 M(+5.3%) | -$22.92 M(-9.4%) |
| Sep 2023 | - | -$5.22 M(-17.7%) | -$25.31 M(-9.8%) |
| Jun 2023 | - | -$6.34 M(+8.4%) | -$28.07 M(-4.6%) |
| Mar 2023 | - | -$5.85 M(-25.8%) | -$29.43 M(-4.9%) |
| Dec 2022 | -$30.95 M | -$7.89 M(-1.2%) | -$30.95 M(+5.2%) |
| Sep 2022 | - | -$7.99 M(+3.8%) | -$29.42 M(-15.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$7.70 M(+4.4%) | -$34.81 M(+6.4%) |
| Mar 2022 | - | -$7.37 M(+15.9%) | -$32.72 M(+15.0%) |
| Dec 2021 | -$28.36 M(+105.5%) | -$6.36 M(-52.4%) | -$28.45 M(+24.0%) |
| Sep 2021 | - | -$13.38 M(+138.3%) | -$22.94 M(+53.3%) |
| Jun 2021 | - | -$5.61 M(+80.9%) | -$14.97 M(+60.0%) |
| Mar 2021 | - | -$3.10 M(+265.8%) | -$9.35 M(+49.6%) |
| Dec 2020 | -$13.80 M(-38.0%) | -$848.20 K(-84.3%) | -$6.25 M(+15.7%) |
| Sep 2020 | - | -$5.40 M | -$5.40 M |
| Dec 2019 | -$22.24 M | - | - |
FAQ
- What is MiNK Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for MiNK Therapeutics?
- What is MiNK Therapeutics annual EBIT year-on-year change?
- What is MiNK Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for MiNK Therapeutics?
- What is MiNK Therapeutics quarterly EBIT year-on-year change?
- What is MiNK Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for MiNK Therapeutics?
- What is MiNK Therapeutics TTM EBIT year-on-year change?
What is MiNK Therapeutics annual earnings before interest & taxes?
The current annual EBIT of INKT is -$22.92 M
What is the all time high annual EBIT for MiNK Therapeutics?
MiNK Therapeutics all-time high annual earnings before interest & taxes is -$13.80 M
What is MiNK Therapeutics annual EBIT year-on-year change?
Over the past year, INKT annual earnings before interest & taxes has changed by +$8.03 M (+25.94%)
What is MiNK Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of INKT is -$1.88 M
What is the all time high quarterly EBIT for MiNK Therapeutics?
MiNK Therapeutics all-time high quarterly earnings before interest & taxes is -$848.20 K
What is MiNK Therapeutics quarterly EBIT year-on-year change?
Over the past year, INKT quarterly earnings before interest & taxes has changed by $0.00 (0.00%)
What is MiNK Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of INKT is -$14.29 M
What is the all time high TTM EBIT for MiNK Therapeutics?
MiNK Therapeutics all-time high TTM earnings before interest & taxes is -$5.40 M
What is MiNK Therapeutics TTM EBIT year-on-year change?
Over the past year, INKT TTM earnings before interest & taxes has changed by $0.00 (0.00%)